1|0|Public
50|$|<b>Lidanserin</b> (INN; ZK-33,839) {{is a drug}} {{which acts}} as a {{combined}} 5-HT2A and Î±1-adrenergic receptor antagonist. It was developed as an antihypertensive agent but was never marketed.|$|E

